Clough Capital Partners L P Zimmer Biomet Holdings, Inc. Transaction History

Clough Capital Partners L P

$924 Million
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$110.76 - $143.18 $4.58 Million - $5.93 Million	41,390 Added 63.22%	106,860 $12 Million
Q2 2023 Aug 14, 2023	BUY	$126.43 - $145.6 $1.16 Million - $1.34 Million	9,200 Added 16.35%	65,470 $9.53 Million
Q1 2023 May 15, 2023	SELL	$121.91 - $130.94 $5.43 Million - $5.83 Million	-44,530 Reduced 44.18%	56,270 $7.27 Million
Q4 2022 Feb 14, 2023	BUY	$104.7 - $128.4 $8.62 Million - $10.6 Million	82,340 Added 446.05%	100,800 $12.9 Million
Q3 2022 Nov 14, 2022	SELL	$101.65 - $119.27 $30,495 - $35,781	-300 Reduced 1.6%	18,460 $1.93 Million
Q2 2022 Aug 16, 2022	SELL	$102.23 - $133.85 $7.7 Million - $10.1 Million	-75,320 Reduced 80.06%	18,760 $1.97 Million
Q1 2022 May 16, 2022	BUY	$108.42 - $129.58 $10.2 Million - $12.2 Million	94,080 New	94,080 $12 Million
Q4 2021 Feb 14, 2022	SELL	$115.43 - $146.63 $6.32 Million - $8.03 Million	-54,770 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$136.35 - $158.76 $8.4 Million - $9.77 Million	-61,570 Reduced 52.92%	54,770 $8.02 Million
Q2 2021 Aug 16, 2021	BUY	$152.95 - $173.41 $15.5 Million - $17.6 Million	101,575 Added 687.94%	116,340 $18.7 Million
Q1 2021 May 17, 2021	SELL	$148.16 - $159.71 $85,932 - $92,631	-580 Reduced 3.78%	14,765 $2.36 Million
Q4 2020 Feb 16, 2021	BUY	$128.25 - $151.41 $454,005 - $535,991	3,540 Added 29.99%	15,345 $2.37 Million
Q2 2020 Aug 14, 2020	SELL	$87.02 - $133.4 $561,714 - $861,097	-6,455 Reduced 35.35%	11,805 $1.41 Million
Q1 2020 May 15, 2020	BUY	$78.28 - $155.73 $1.43 Million - $2.84 Million	18,260 New	18,260 $1.85 Million

Others Institutions Holding ZBH

# of Institutions

1,080

Shares Held

179M

Call Options Held

301K

Put Options Held

View Full List

About ZIMMER BIOMET HOLDINGS, INC.

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $23.1B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

More about ZBH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.

Account